CD39/adenosine pathway is involved in AIDS progression

PLoS Pathogens

Volumn 7, Issue 7, 2011, Pages

  Nikolova, Maria ^a,b   Carriere, Matthieu ^a   Jenabian, Mohammad Ali ^a   Limou, Sophie ^a,c   Younas, Mehwish ^a   Kök, Ayrin ^a   Huë, Sophie ^a   Seddiki, Nabila ^a   Hulin, Anne ^d   Delaneau, Olivier ^c   Schuitemaker, Hanneke ^e   Herbeck, Joshua T ^f   Mullins, James I ^f   Muhtarova, Maria ^b   Bensussan, Armand ^g   Zagury, Jean François ^a,c   Lelievre, Jean Daniel ^a,d,h   Lévy, Yves ^a,d,h  

^a INSERM U955   (France)

^b NATIONAL CENTER OF INFECTIOUS AND PARASITIC DISEASES   (Bulgaria)

^c Unité de Recherches Mesures Physiques Métrologie   (France)

^d HENRI MONDOR HOSPITAL   (France)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^g UNIVERSITÉ PARIS DESCARTES   (France)

^h FACULTÉ DE MÉDECINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE; ADENOSINE A2A RECEPTOR; ADENOSINE RECEPTOR STIMULATING AGENT; CD39 ANTIGEN; ENTPD1 PROTEIN; PROTEIN; UNCLASSIFIED DRUG; APYRASE; BIOLOGICAL MARKER; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CONTROLLED STUDY; DISEASE COURSE; DNA POLYMORPHISM; DOWN REGULATION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; PATHOGENESIS; PHENOTYPE; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; BULGARIA; CELL CULTURE; CELL PROLIFERATION; FRANCE; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MORTALITY; SURVIVAL RATE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ADENOSINE; ANTIGENS, CD; APYRASE; BIOLOGICAL MARKERS; BULGARIA; CELL PROLIFERATION; CELLS, CULTURED; DISEASE PROGRESSION; DOWN-REGULATION; FORKHEAD TRANSCRIPTION FACTORS; FRANCE; GENE EXPRESSION; HIV INFECTIONS; HUMANS; LYMPHOCYTE ACTIVATION; POLYMORPHISM, GENETIC; RECEPTOR, ADENOSINE A2A; SURVIVAL RATE; T-LYMPHOCYTES, REGULATORY;

EID: 79960931448     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002110     Document Type: Article

References (54)

1. Appay V, Nixon DF, Donahoe SM, Gillespie GM, Dong T, et al. (2000) HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med 192: 63-75.
2. Aandahl EM, Michaelsson J, Moretto WJ, Hecht FM, Nixon DF, (2004) Human CD4+CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J Virol 78: 2454-2459.
3. Cabrera R, Tu Z, Xu Y, Firpi RJ, Rosen HR, et al. (2004) An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology 40: 1062-1071.
4. Kinter AL, Hennessey M, Bell A, Kern S, Lin Y, et al. (2004) CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J Exp Med 200: 331-343.
5. Kared H, Lelievre JD, Donkova-Petrini V, Aouba A, Melica G, et al. (2008) HIV-specific regulatory T cells are associated with higher CD4 cell counts in primary infection. AIDS 22: 2451-2460.
6. Weiss L, Donkova-Petrini V, Caccavelli L, Balbo M, Carbonneil C, et al. (2004) Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood 104: 3249-3256.
7. Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, et al. (2007) The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450: 566-569.
8. Paust S, Lu L, McCarty N, Cantor H, (2004) Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc Natl Acad Sci U S A 101: 10398-10403.
9. Vignali DA, Collison LW, Workman CJ, (2008) How regulatory T cells work. Nat Rev Immunol 8: 523-532.
10. Borsellino G, Kleinewietfeld M, Di Mitri D, Sternjak A, Diamantini A, et al. (2007) Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 110: 1225-1232.
11. Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, et al. (2007) Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 204: 1257-1265.
12. Mandapathil M, Szczepanski MJ, Szajnik M, Ren J, Lenzner DE, et al. (2009) Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer. Clin Cancer Res 15: 6348-6357.
13. Airas L, Hellman J, Salmi M, Bono P, Puurunen T, et al. (1995) CD73 is involved in lymphocyte binding to the endothelium: characterization of lymphocyte-vascular adhesion protein 2 identifies it as CD73. J Exp Med 182: 1603-1608.
14. Bours MJ, Swennen EL, Di Virgilio F, Cronstein BN, Dagnelie PC, (2006) Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther 112: 358-404.
15. Robson SC, Sevigny J, Zimmermann H, (2006) The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance. Purinergic Signal 2: 409-430.
16. Sitkovsky MV, Lukashev D, Apasov S, Kojima H, Koshiba M, et al. (2004) Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annu Rev Immunol 22: 657-682.
17. Thiel M, Caldwell CC, Sitkovsky MV, (2003) The critical role of adenosine A2A receptors in downregulation of inflammation and immunity in the pathogenesis of infectious diseases. Microbes Infect 5: 515-526.
18. Huang S, Apasov S, Koshiba M, Sitkovsky M, (1997) Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. Blood 90: 1600-1610.
19. Maliszewski CR, Delespesse GJ, Schoenborn MA, Armitage RJ, Fanslow WC, et al. (1994) The CD39 lymphoid cell activation antigen. Molecular cloning and structural characterization. J Immunol 153: 3574-3583.
20. Hendel H, Caillat-Zucman S, Lebuanec H, Carrington M, O'Brien S, et al. (1999) New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS. J Immunol 162: 6942-6946.
21. Friedman DJ, Kunzli BM, Yi AR, Sevigny J, Berberat PO, et al. (2009) From the Cover: CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease. Proc Natl Acad Sci U S A 106: 16788-16793.
22. Le Clerc S, Limou S, Coulonges C, Carpentier W, Dina C, et al. (2009) Genomewide association study of a rapid progression cohort identifies new susceptibility alleles for AIDS (ANRS Genomewide Association Study 03). J Infect Dis 200: 1194-1201.
23. Limou S, Le Clerc S, Coulonges C, Carpentier W, Dina C, et al. (2009) Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02). J Infect Dis 199: 419-426.
24. Ge D, Zhang K, Need AC, Martin O, Fellay J, et al. (2008) WGAViewer: software for genomic annotation of whole genome association studies. Genome Res 18: 640-643.
25. Dixon AL, Liang L, Moffatt MF, Chen W, Heath S, et al. (2007) A genome-wide association study of global gene expression. Nat Genet 39: 1202-1207.
26. Dwyer KM, Deaglio S, Gao W, Friedman D, Strom TB, et al. (2007) CD39 and control of cellular immune responses. Purinergic Signal 3: 171-180.
27. Mandapathil M, Lang S, Gorelik E, Whiteside TL, (2009) Isolation of functional human regulatory T cells (Treg) from the peripheral blood based on the CD39 expression. J Immunol Methods 346: 55-63.
28. Leal DB, Streher CA, Bertoncheli Cde M, Carli LF, Leal CA, et al. (2005) HIV infection is associated with increased NTPDase activity that correlates with CD39-positive lymphocytes. Biochim Biophys Acta 1746: 129-134.
29. Schulze Zur Wiesch J, Thomssen A, Hartjen P, Toth I, Lehmann C, et al. (2011) Comprehensive Analysis of Frequency and Phenotype of T Regulatory Cells in HIV Infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease. J Virol 85: 1287-1297.
30. Nigam P, Velu V, Kannanganat S, Chennareddi L, Kwa S, et al. (2010) Expansion of FOXP3+ CD8 T cells with suppressive potential in colorectal mucosa following a pathogenic Simian Immunodeficiency Virus infection correlates with diminished antiviral T cell response and viral control. J Immunol 184: 1690-1701.
31. Burnstock G, (2006) Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol Rev 58: 58-86.
32. Martin C, Leone M, Viviand X, Ayem ML, Guieu R, (2000) High adenosine plasma concentration as a prognostic index for outcome in patients with septic shock. Crit Care Med 28: 3198-3202.
33. Ogura Y, Sutterwala FS, Flavell RA, (2006) The inflammasome: first line of the immune response to cell stress. Cell 126: 659-662.
34. Erdmann AA, Gao ZG, Jung U, Foley J, Borenstein T, et al. (2005) Activation of Th1 and Tc1 cell adenosine A2A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo. Blood 105: 4707-4714.
35. Ohta A, Sitkovsky M, (2001) Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414: 916-920.
36. Ohta A, Ohta A, Madasu M, Kini R, Subramanian M, et al. (2009) A2A adenosine receptor may allow expansion of T cells lacking effector functions in extracellular adenosine-rich microenvironments. J Immunol 183: 5487-5493.
37. Zarek PE, Huang CT, Lutz ER, Kowalski J, Horton MR, et al. (2008) A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. Blood 111: 251-259.
38. Kobie JJ, Shah PR, Yang L, Rebhahn JA, Fowell DJ, et al. (2006) T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5′-adenosine monophosphate to adenosine. J Immunol 177: 6780-6786.
39. Aswad F, Kawamura H, Dennert G, (2005) High sensitivity of CD4+CD25+ regulatory T cells to extracellular metabolites nicotinamide adenine dinucleotide and ATP: a role for P2X7 receptors. J Immunol 175: 3075-3083.
40. Dong RP, Kameoka J, Hegen M, Tanaka T, Xu Y, et al. (1996) Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response. J Immunol 156: 1349-1355.
41. Sitkovsky MV, Ohta A, (2005) The 'danger' sensors that STOP the immune response: the A2 adenosine receptors? Trends Immunol 26: 299-304.
42. Gajewski TF, Meng Y, Harlin H, (2006) Immune suppression in the tumor microenvironment. J Immunother 29: 233-240.
43. Kinter A, McNally J, Riggin L, Jackson R, Roby G, et al. (2007) Suppression of HIV-specific T cell activity by lymph node CD25+ regulatory T cells from HIV-infected individuals. Proc Natl Acad Sci U S A 104: 3390-3395.
44. Estes JD, Li Q, Reynolds MR, Wietgrefe S, Duan L, et al. (2006) Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection. J Infect Dis 193: 703-712.
45. Lichterfeld M, Kaufmann DE, Yu XG, Mui SK, Addo MM, et al. (2004) Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells. J Exp Med 200: 701-712.
46. Nikolova M, Lelievre JD, Carriere M, Bensussan A, Levy Y, (2009) Regulatory T cells differentially modulate the maturation and apoptosis of human CD8+ T-cell subsets. Blood 113: 4556-4565.
47. Gouttefangeas C, Mansur I, Bensussan A, Boumsell L, (1995) Biochemical analysis and epitope mapping of mAb defining CD39. In: Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, editors. Leucocyte Typing V New York Oxford University Press pp. 383-385.
48. Winkler CA, Hendel H, Carrington M, Smith MW, Nelson GW, et al. (2004) Dominant effects of CCR2-CCR5 haplotypes in HIV-1 disease progression. J Acquir Immune Defic Syndr 37: 1534-1538.
49. Balkau B, (1996) [An epidemiologic survey from a network of French Health Examination Centres, (D.E.S.I.R.): epidemiologic data on the insulin resistance syndrome]. Rev Epidemiol Sante Publique 44: 373-375.
50. van Manen D, Kootstra NA, Boeser-Nunnink B, Handulle MA, van't Wout AB, et al. (2009) Association of HLA-C and HCP5 gene regions with the clinical course of HIV-1 infection. AIDS 23: 19-28.
51. Herbeck JT, Gottlieb GS, Winkler CA, Nelson GW, An P, et al. (2010) Multistage genomewide association study identifies a locus at 1q41 associated with rate of HIV-1 disease progression to clinical AIDS. J Infect Dis 201: 618-626.
52. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, et al. (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38: 904-909.
53. Marchini J, Howie B, Myers S, McVean G, Donnelly P, (2007) A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 39: 906-913.
54. Fisher RA, Immer FR, Tedin O, (1932) The Genetical Interpretation of Statistics of the Third Degree in the Study of Quantitative Inheritance. Genetics 17: 107-124.